Healthcare Business Review : News

Leading independent healthcare waste management specialist Anenta is celebrating having been named UK Healthcare Waste Management Services Company of the Year for the second year running at the Healthcare Business Review Europe Awards 2026 .   The back-to-back win reinforces Anenta’s position as the UK’s leading independent healthcare waste management company, recognising the continued impact of its technology-led approach, sector expertise and commitment to driving efficiency, compliance and cost control across healthcare estates.  Anenta was selected following a rigorous evaluation by a panel of C-suite executives, industry experts, and the editorial board of Healthcare Business Review. Judges highlighted the continued evolution of Anenta’s proprietary Vector platform, alongside the company’s proven ability to deliver measurable financial and operational benefits for healthcare organisations.    Saving clients millions   Highlights identified by the judges include Anenta’s work to save primary care clients over £13m in charges and the equivalent of £35m in efficiencies by cutting the amount of client staff time spent handling waste administration, auditing and dispute resolution.  This has been made possible through Anenta’s use of its proprietary Vector technology, which analyses hundreds of thousands of data points each month to identify any instances of waste collection or disposal partner billing inaccuracies so that these can be addressed before payment.  This rigorous yet collaborative approach, which identifies and addresses cases of overbilling, contract non-compliance or inefficiencies, was described by the judges as ‘setting a benchmark for best practice, valued by both healthcare providers and waste contractors for its focus on transparency, accuracy and continuous improvement.’  Alex D’Souza, Managing Editor of Healthcare Business Review Europe , commented on the award, saying: “Anenta continues to stand head and shoulders above other healthcare waste management service providers. Retaining this award reflects both Anenta’s consistency and outstanding leadership, as it continues to set itself apart through innovation, depth of sector knowledge and a clear focus on delivering tangible outcomes for healthcare organisations.”  D’Souza added: “The 2026 award recognises Anenta’s continued leadership in supporting NHS Integrated Care Boards (ICBs), helping unify complex waste arrangements under a single service specification, with consistent contract terms and a common environmental model. This scalable approach is raising standards across the healthcare waste management landscape, setting the bar for efficiency and collaboration.”  Graham Flynn, Managing Director of Anenta, commented: “This is a tremendous endorsement of our team, our technology and our approach. It is particularly meaningful because recognition comes from senior decision-makers who understand the operational and compliance pressures facing healthcare providers.”  Graham added: “As we move through 2026, we look forward to making a significant difference to an increasing number of businesses in the healthcare sector, enhancing levels of efficiency, compliance and cost control for healthcare estates, private healthcare businesses, dentists and care homes. Our focus remains on being a trusted partner — helping organisations operate with confidence, while continuously raising standards of healthcare waste management across the sector.”  Future growth   Looking ahead, Anenta aims to build strong growth across its client base, with dental practices and care homes identified as key expansion areas. This reflects increasing regulatory scrutiny and risk in these environments, where correct segregation and management of clinical and healthcare waste is critical and time-consuming.  Anenta currently acts on behalf of more than 9,000 GP practices and 9,000 pharmacies across England, handling in excess of 39,000 healthcare waste management queries each year. It supports NHS organisations, GP practices, pharmacies, laboratories, dental practices and care homes. Its services include the provision of remote duty of care, and pre-acceptance audits, supported by free, standardised e-learning programmes. This approach helps clients meet their compliance obligations while reducing risk, enabling healthcare organisations to focus frontline teams on patient and resident care rather than administrative burdens associated with waste management.   ...Read more

Dental practices are increasingly turning to fractional CFO services to improve their financial management, streamline operations, and position themselves for sustainable growth. These specialized services offer practices expert financial leadership without the expense of hiring a full-time executive. By combining industry-specific knowledge with advanced analytical tools, fractional CFOs help practices make informed decisions, enhance profitability, and ensure long-term stability. Their role goes beyond basic bookkeeping, focusing on strategic planning, cash flow optimization, and risk management tailored to the unique needs of the dental sector. Enhancing Financial Strategy and Performance Fractional CFO services provide dental practices with high-level financial oversight that aligns daily operations with long-term objectives. These professionals develop customized budgeting systems, implement performance tracking metrics, and identify cost-saving opportunities without compromising patient care. Through detailed financial forecasting, they help practices anticipate market changes, plan for expansions, and allocate resources effectively. By evaluating key performance indicators, they ensure that financial strategies remain aligned with practice goals, enabling sustained growth. Revenue cycle management is another critical area where fractional CFOs add value. They optimize billing processes, reduce claim denials, and improve collection rates, ensuring that practices maintain healthy cash flow. Detailed financial analysis also uncovers underperforming services or inefficient processes, allowing for timely adjustments. The result is a more agile, data-driven approach to decision-making that supports operational efficiency and competitive positioning in the market. Leveraging Technology and Compliance Expertise Advancements in financial technology have greatly enhanced the capabilities of dental fractional CFO services. Automated reporting systems, real-time analytics dashboards, and cloud-based accounting tools provide more accurate and timely financial insights. Firms such as Serenity contribute to financial analysis by supporting dental practices with structured insights and operational guidance. These technologies enable fractional CFOs to monitor performance continuously, address issues quickly, and provide actionable recommendations during critical decision-making. Expertise in compliance is a significant advantage. Fractional CFOs ensure practices adhere to industry regulations, tax requirements, and labor laws, reducing the risk of costly penalties. They also assist in structuring contracts, managing vendor relationships, and evaluating investment opportunities to safeguard the practice's financial health. Top Notch Finders delivers technology-driven solutions that enhance financial insights and analytics within complex operational environments. By combining strategic insight, technological proficiency, and regulatory knowledge, fractional CFOs empower dental practices to navigate challenges while seizing opportunities. Their guidance enables dentists to focus more on patient care, confident that the financial side of their practice is in expert hands. ...Read more

Regenerative medicine is an innovative field that has the potential to transform healthcare by restoring function to damaged tissues and organs. Recent advancements have brought these ambitious goals closer to reality, providing new hope for patients suffering from chronic diseases, injuries, and degenerative conditions. Stem cell therapy is at the forefront of regenerative medicine, with recent improvements enhancing its efficacy and safety. Researchers can now isolate specific types of stem cells from various sources, including adult tissues, umbilical cord blood, and even induced pluripotent stem cells (iPSCs). Recent clinical trials have demonstrated encouraging results in the treatment of various conditions, including spinal cord injuries, heart disease, and neurodegenerative disorders such as Parkinson’s disease. These findings promise to advance therapeutic approaches in these challenging medical conditions. For instance, a groundbreaking trial demonstrated how injecting iPSCs directly into spinal cord injury sites improved patient motor function recovery. Advancements in gene editing technologies, such as CRISPR, have enabled researchers to enhance the therapeutic potential of stem cells by correcting genetic defects before they are administered to patients. This confluence of stem cell research and genetic engineering holds immense potential for personalized medicine. Tissue Engineering: Creating Functional Organs Tissue engineering combines biology, materials science, and engineering techniques to create biological substitutes that restore, maintain, and improve damaged tissues and organs. A significant breakthrough in this area is the development of 3D bioprinting technology, which allows the layered deposition of living cells to fabricate biomimetic structures that closely resemble natural tissues. Gene Editing: A New Frontier In Regenerative Medicine Gene editing technologies are revolutionizing regenerative medicine by enabling precise modifications to the genetic material within living cells. CRISPR-Cas9, in particular, has garnered attention due to its simplicity and efficiency. Organizations such as  Atlantic Dental Consulting   support advancements in healthcare technology by aligning clinical processes with evolving treatment frameworks and precision-driven approaches. This technology allows researchers to target specific genes for editing, paving the way for potential treatments for genetic disorders where traditional approaches have been limited. Recent innovations have created functional tissue constructs for various applications, including skin grafts for burn victims, cartilage for joint repair, and even miniaturized organ models for drug testing. For example, researchers have successfully printed human skin for patients with severe wounds in clinical settings. Furthermore, advances in vascularization techniques have improved the ability to integrate these engineered tissues into the body, enhancing their survival and functionality. Spacetalk delivers technology solutions that support engineering precision and data-driven innovation across advanced operational environments. Recent studies have demonstrated the ability of gene editing to correct mutations responsible for conditions such as sickle cell disease and muscular dystrophy. For instance, scientists have successfully used CRISPR to modify hematopoietic stem cells from patients with sickle cell disease, producing healthy red blood cells after transplantation. Moreover, gene therapy combined with stem cell approaches has shown promise in treating certain cancers by enhancing the body’s immune response. ...Read more